Effects of uremic plasma on α- and β-adrenoceptor subtypes

被引:11
作者
Ferchland, A
Rettkowski, O
Pönicke, K
Deuber, HJ
Osten, B
Brodde, OE
机构
[1] Univ Halle Wittenberg, Inst Pharmacol & Toxicol, D-06097 Halle, Germany
[2] Univ Halle Wittenberg, Dept Nephrol, D-06097 Halle, Germany
来源
NEPHRON | 1998年 / 80卷 / 01期
关键词
hemodialysis; beta-adrenoceptors; alpha-adrenoceptors;
D O I
10.1159/000045124
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Responsiveness of adrenergic receptors is decreased in patients on maintenance hemodialysis. In this study we investigated whether uremic plasma might affect adrenergic receptors. For this purpose we determined the effects of uremic plasma obtained from 10 patients on hemodialysis treatment (mean age 61 +/- 3 years, dialysis frequency 3 x 4 h/week, duration of treatment 3 +/- 1 years) before and at the end of the 4-hour dialysis treatment on binding of radioligands to beta(1)- and beta(2)- as well as alpha(1)- and alpha(2)-adrenoceptors. Plasma from 6 healthy volunteers served as control; the plasmas were studied in three dilutions: undiluted, 1:1 (v/v) and 1:4 (v/v) with saline diluted. Plasma from healthy control did not significantly affect the number of beta(1)- and beta(2)- or alpha(1)- and alpha 2-adrenoceptors. On the other hand, uremic plasma significantly decreased the number of beta(1)- and beta(2)-adrenoceptors; this inhibitory effect was also observed when plasma obtained at the end of the 4-hour dialysis treatment was investigated. On the other hand, uremic plasma did not significantly decrease the number of alpha(1)- and alpha(2)-adrenoceptors. We conclude that in patients on maintenance hemodialysis, the presence of inhibitory substance(s) in uremic plasma could be - at least partly - responsible for the beta-adrenoceptor hyporesponsiveness; the mechanism leading ot alpha-adrenoceptor hyporesponsiveness, however, remains to be elucidated.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 23 条
[1]   Autonomic nervous system and adrenergic receptors in chronic hypotensive haemodialysis patients [J].
Armengol, NE ;
Amenos, AC ;
Illa, MB ;
Bertran, JG ;
Ginesta, JC ;
Fillat, FR .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (05) :939-944
[2]  
BOTEY A, 1981, P EUR DIAL TRANS, V18, P586
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
BREE F, 1987, BIOCHEM PHARMACOL, V19, P3121
[5]  
Brodde O E, 1986, Contrib Nephrol, V50, P28
[6]  
Brodde O E, 1984, Contrib Nephrol, V41, P99
[7]   CORRELATION BETWEEN HUMAN MYOMETRIAL AND PLATELET ALPHA-2-ADRENOCEPTOR DENSITY [J].
BRODDE, OE ;
SEHER, U ;
NOHLEN, M ;
FISCHER, WM ;
MICHEL, MC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 150 (03) :403-404
[8]   SPARE RECEPTORS FOR BETA-ADRENOCEPTOR-MEDIATED POSITIVE INOTROPIC EFFECTS OF CATECHOLAMINES IN THE HUMAN HEART [J].
BROWN, L ;
DEIGHTON, NM ;
BALS, S ;
SOHLMANN, W ;
ZERKOWSKI, HR ;
MICHEL, MC ;
BRODDE, OE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 (02) :222-232
[9]   MECHANISMS OF AUTONOMIC NERVOUS-SYSTEM DYSFUNCTION IN UREMIA [J].
CAMPESE, VM ;
ROMOFF, MS ;
LEVITAN, D ;
LANE, K ;
MASSRY, SG .
KIDNEY INTERNATIONAL, 1981, 20 (02) :246-253
[10]   ARTERIAL-HYPOTENSION IN CHRONIC HEMODIALYZED PATIENTS [J].
DAUL, AE ;
WANG, XL ;
MICHEL, MC ;
BRODDE, OE .
KIDNEY INTERNATIONAL, 1987, 32 (05) :728-735